Logo image
From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies
Journal article   Open access   Peer reviewed

From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies

Emily McLeish, Nataliya Slater, Frank L Mastaglia, Merrilee Needham and Jerome D Coudert
Briefings in bioinformatics, Vol.25(1), bbad514
2023
PMID: 38243695
pdf
Published1.19 MBDownloadView
CC BY V4.0 Open Access

Abstract

Adult Autoimmune Diseases Biomarkers Dermatomyositis - diagnosis Disease Progression Humans Myositis - diagnosis Myositis - therapy
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of muscle disorders including adult and juvenile dermatomyositis, polymyositis, immune-mediated necrotising myopathy and sporadic inclusion body myositis, all of which present with variable symptoms and disease progression. The identification of effective biomarkers for IIMs has been challenging due to the heterogeneity between IIMs and within IIM subgroups, but recent advances in machine learning (ML) techniques have shown promises in identifying novel biomarkers. This paper reviews recent studies on potential biomarkers for IIM and evaluates their clinical utility. We also explore how data analytic tools and ML algorithms have been used to identify biomarkers, highlighting their potential to advance our understanding and diagnosis of IIM and improve patient outcomes. Overall, ML techniques have great potential to revolutionize biomarker discovery in IIMs and lead to more effective diagnosis and treatment.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Metrics

3 File views/ downloads
93 Record Views
Logo image